{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:27:04Z","timestamp":1787023624832,"version":"build-2736575974"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,11]]},"DOI":"10.18632\/oncotarget.17598","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T04:32:54Z","timestamp":1493872374000},"page":"46234-46248","source":"Crossref","is-referenced-by-count":50,"title":["Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis"],"prefix":"10.18632","volume":"8","author":[{"given":"Mirko","family":"Dengler","sequence":"first","affiliation":[{"name":"Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Staufer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Transplantation, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidemarie","family":"Huber","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Stauber","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Bantel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Heinz","family":"Weiss","sequence":"additional","affiliation":[{"name":"University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Starlinger","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of General Surgery, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Pock","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kl\u00f6ters-Plachky","sequence":"additional","affiliation":[{"name":"University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Gotthardt","sequence":"additional","affiliation":[{"name":"University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rauch","sequence":"additional","affiliation":[{"name":"Candor Bioscience GmbH, Wangen im Allg\u00e4u, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Lackner","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Stift","sequence":"additional","affiliation":[{"name":"Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Brostjan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of General Surgery, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gruenberger","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of General Surgery, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kumada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Center for Liver Cell Research, Children's University Hospital (KUNO), University of Regensburg Hospital, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Mikulits","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Institute of Cancer Research, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"Rudolph","year":"2007","journal-title":"Gastroenterology"},{"key":"2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Bruix","year":"2012","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1872-034X.2010.00731.x","article-title":"Report of the 18th follow-up survey of primary liver cancer in Japan","volume":"40","author":"Monden","year":"2010","journal-title":"Hepatol Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","volume":"27","author":"Reichman","year":"2009","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Bruix","year":"1999","journal-title":"Hepatology"},{"key":"6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Sherman","year":"2011","journal-title":"Hepatology"},{"key":"7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The Liver, European Organisation For Research and Treatment Of Cancer","year":"2012","journal-title":"J Hepatol"},{"key":"8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","author":"Marrero","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000111717","article-title":"Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein","volume":"72","author":"Acharya","year":"2007","journal-title":"Oncology"},{"key":"10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/hep.24033","article-title":"Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases","volume":"53","author":"El-Serag","year":"2011","journal-title":"Hepatology"},{"key":"11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1440-1746.2008.05395.x","article-title":"Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma","volume":"23","author":"Tong","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1470-2045(12)70233-4","article-title":"Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study","volume":"13","author":"Yu","year":"2012","journal-title":"Lancet Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10620-006-9541-2","article-title":"Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States","volume":"52","author":"Satomura","year":"2007","journal-title":"Dig Dis Sci"},{"key":"15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3892\/or.2016.4842","article-title":"Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: an update for clinicians","volume":"36","author":"Mikulits","year":"2016","journal-title":"Oncol Rep"},{"key":"16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1538-7836.2010.03752.x","article-title":"Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood","volume":"8","author":"Dahlback","year":"2010","journal-title":"J Thromb Haemost"},{"key":"17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1074\/jbc.270.2.551","article-title":"The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage","volume":"270","author":"Liu","year":"1995","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"a009076","DOI":"10.1101\/cshperspect.a009076","article-title":"Biology of the TAM receptors","volume":"5","author":"Lemke","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinbiochem.2009.07.025","article-title":"Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms","volume":"43","author":"Dahlback","year":"2010","journal-title":"Clin Biochem"},{"key":"20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/rheumatology\/keq459","article-title":"Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus","volume":"50","author":"Dahlback","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0961203314520839","article-title":"Different expression patterns and clinical significance of mAxl and sAxl in systemic lupus erythematosus","volume":"23","author":"Su","year":"2014","journal-title":"Lupus"},{"key":"22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clinbiochem.2013.11.001","article-title":"Plasma concentrations of sAxl are associated with severe preeclampsia","volume":"47","author":"Zhou","year":"2014","journal-title":"Clin Biochem"},{"key":"23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.27492","article-title":"Axl activates autocrine transforming growth factor-beta signaling in hepatocellular carcinoma","volume":"61","author":"Mikulits","year":"2015","journal-title":"Hepatology"},{"key":"24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.29394","article-title":"Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma","volume":"137","author":"Man","year":"2015","journal-title":"Int J Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2015.04.013","article-title":"Gas6\/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation","volume":"63","author":"Morales","year":"2015","journal-title":"J Hepatol"},{"key":"26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hep.21237","article-title":"Induction of Gas6 protein in CCl4-induced rat liver injury and anti-apoptotic effect on hepatic stellate cells","volume":"44","author":"Laperche","year":"2006","journal-title":"Hepatology"},{"key":"27","doi-asserted-by":"crossref","first-page":"G1043","DOI":"10.1152\/ajpgi.00311.2010","article-title":"Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice","volume":"300","author":"Brouillet","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2009.02.030","article-title":"Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice","volume":"51","author":"Brouillet","year":"2009","journal-title":"J Hepatol"},{"key":"29","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/0008-5472.CAN-11-3317","article-title":"Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma","volume":"72","author":"Clement","year":"2012","journal-title":"Cancer Res"},{"key":"30","first-page":"141","article-title":"Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease","volume":"31","author":"Baba","year":"2016","journal-title":"Histol Histopathol"},{"key":"31","doi-asserted-by":"crossref","first-page":"e0151069","DOI":"10.1371\/journal.pone.0151069","article-title":"Diagnostic performance of alpha-fetoprotein, protein induced by Vitamin K absence, osteopontin, Dickkopf-1 and its combinations for hepatocellular carcinoma","volume":"11","author":"Brechot","year":"2016","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/carcin\/bgs372","article-title":"Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma","volume":"34","author":"Zhao","year":"2013","journal-title":"Carcinogenesis"},{"key":"33","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.18632\/oncotarget.3314","article-title":"Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma","volume":"6","author":"Shen","year":"2015","journal-title":"Oncotarget"},{"key":"34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/adt.2016.743","article-title":"Accurate determination of soluble Axl by enzyme linked immunosorbent assay","volume":"14","author":"Mikulits","year":"2016","journal-title":"Assay Drug Dev Technol"},{"key":"35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status","volume":"34","author":"Bernardi","year":"2001","journal-title":"J Hepatol"},{"key":"36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1756283X10385964","article-title":"Surveillance for hepatocellular carcinoma: in whom and how?","volume":"4","author":"Davila","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ijc.28953","article-title":"Osteopontin and latent-TGF beta binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma","volume":"136","author":"Lee","year":"2015","journal-title":"Int J Cancer"},{"key":"38","first-page":"840","article-title":"The significance of serum AFP cut-off values, 20 and 400 ng\/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of difference","volume":"59","author":"Qu","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjc.6604440","article-title":"New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis","volume":"99","author":"Majdic","year":"2008","journal-title":"Br J Cancer"},{"key":"40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ijc.2910520217","article-title":"Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells","volume":"52","author":"Whiteside","year":"1992","journal-title":"Int J Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T13:00:51Z","timestamp":1594818051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":40,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2017,7,11]]}},"alternative-id":["17598","28526812"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17598","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]}}}